ppFEV 1 (P < 10 24 ) belong to the T H 1 or IL-12 cytokine family pathway. By using a linear additive model, these 4 T H 1 pathway SNPs cumulatively explained 2.9% to 7.8% of the variance in ppFEV 1 values in 4 populations (P 5 3 3 10 211 ). Genetic scores of these 4 SNPs were associated with ppFEV 1 values (P 5 2 3 10
27
) and the American Thoracic Society severe asthma classification (P 5 .005) in the Severe Asthma Research Program population. T H 2 pathway genes (IL13, TSLP, IL33, and IL1RL1) conferring asthma susceptibility were not associated with lung function. Conclusion: Genes involved in airway structure/remodeling are associated with lung function in both general populations and asthmatic subjects. T H 1 pathway genes involved in anti-virus/ bacterial infection and inflammation modify lung function in asthmatic subjects. Genes associated with lung function that might affect asthma severity are distinct from those genes associated with asthma susceptibility. Asthma is a chronic inflammatory respiratory disease with a high level of genetic and phenotypic heterogeneity. Phenotypically, asthma can be classified as mild, moderate, or severe according to National Asthma Education and Prevention Program, Global Initiative for Asthma, or American Thoracic Society (ATS) guidelines. [1] [2] [3] Recent work has described 5 distinct asthma severity phenotypes through cluster analysis. 4 Measures of lung function, particularly percent predicted FEV 1 (ppFEV 1 ) values, are essential for categorizing asthma severity by using either current guidelines or cluster methodologies. [1] [2] [3] [4] Three recent large meta-analyses of genome-wide association studies (GWASs) in general populations of European descent have identified 28 loci for lung function [5] [6] [7] : HHIP, HTR4, INTS12-GSTCD-NPNT, TNS1, C10orf11, CDC123, MECOM, and ZKSCAN3-ZNF323 for FEV 1 and ADAM19, DAAM2, FAM13A,  GPR126, HHIP, HTR4, NOTCH4-AGER-PPT2, PID1, PTCH1,  THSD4, ARMC2, CCDC38, CDC123, CFDP1, HDAC4, KCNE2,  LRP1, MFAP2, MMP15, NCR3 , RARB, SPATA9, and TGFB2 for FEV 1 /forced vital capacity (FVC) ratio. In a previous study of candidate genes, we have shown that HHIP is associated with ppFEV 1 and percent predicted forced vital capacity (ppFVC) values in asthmatic subjects. 8 A recent GWAS of lung function decrease has suggested that genetic profiles for longitudinal and cross-sectional lung function differ between subjects with and without asthma. 9 In this study we performed meta-analyses of GWASs of lung function (ppFEV 1 , ppFVC, and FEV 1 /FVC ratio) in 4 European American asthmatic populations to determine whether the 28 loci identified in the previous GWASs for normal variation of lung function are important components affecting abnormal lung function in asthmatic subjects. More importantly, we explored whether some novel genes have large effects on lung function unique to asthmatic subjects.
METHODS

Study subjects
Subjects with mild-to-severe asthma recruited at the National Heart, Lung, and Blood Institute (NHLBI)-funded Severe Asthma Research Program (SARP) centers were carefully characterized, including baseline spirometry with a medication withhold before testing. 3, 4, 8 Similar baseline spirometry was performed in subjects with severe or difficult-to-treat asthma from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) multicenter study. 8, 10, 11 Asthmatic subjects who were studied in the NHLBI's Collaborative Studies on the Genetics of Asthma (CSGA) by the Wake Forest investigators using a similar protocol were included in the analyses. 8 13 The patients from the BASALT trials (ClinicalTrials.gov no. NCT00495157) had mild-tomoderate asthma. The patients from the TALC trials (ClinicalTrials.gov no. NCT00565266) had poorly controlled disease on a lower dose of inhaled corticosteroid. 13 All studies were approved by the appropriate institutional review boards at the participating sites, including obtaining appropriate informed consent.
DNA was isolated by using standard protocols, and single nucleotide polymorphism (SNP) genotyping was performed with the Illumina HumanCNV370 BeadChip (Illumina, San Diego, Calif) for TENOR samples. SARP and CSGA samples were genotyped with the Illumina HumanHap1M BeadChip. ACRN samples were genotyped with the Illumina HumanOmniExpress700k BeadChip. Genotyping for all studies was performed with BeadStudio or GenomeStudio (Illumina).
Statistical analysis
Quality control processes of GWASs for the SARP, CSGA, and TENOR populations have been described previously. 8 Quality control of ACRN cases was performed in a similar manner.
ppFEV 1 16 Association plots were generated with SNAP (version 2.0; http://www.broad.mit.edu/mpg/snap/). 17 Meta-analyses of linear regression slope b with 369,771 SNPs that were shared in all studies from 4 European American populations (SARP, CSGA, TENOR, and ACRN) were performed, with weights proportional to the inverse variance of b using METAL software (http://www.sph.umich.edu/csg/ abecasis/metal/). P values with genomic control adjustment from each population were used for meta-analysis to reduce genomic inflation. Joint analysis of the 4 T H 1 pathway SNPs (rs7636840 in IL12A, rs388159 in IL12RB1, rs925847 in STAT4, and rs3756089 in IRF2) was performed in the SARP population. Genetic scores were defined by the number of risk alleles present in these 4 SNPs. A linear or logistic model was used for analysis of ppFEV 1 values and percentages of subjects with severe asthma by using the ATS asthma severity classification, 3 with genetic scores as defined.
RESULTS
Subjects' demographics
Although the 4 studies were all composed of European American subjects with asthma and use similar clinical approaches to phenotyping cases, they differed in the proportion of subjects with severe asthma. SARP is a cohort enriched for subjects with severe asthma but also well balanced with subjects with mild-tomoderate asthma. TENOR focused on subjects with difficult-totreat or severe asthma. CSGA included all levels of severity but primarily milder levels. The ACRN study is composed of the TALC and BASALT trials, in which BASALT had subjects with mild-tomoderate asthma but TALC focused on subjects with poorly controlled asthma receiving a low dose of inhaled corticosteroids. These phenotypic differences are reflected in baseline lung function (see Table E1 in this article's Online Repository at www.jacionline. org). Only subjects with an age of enrollment of 12 years or greater were included in the analysis to reduce the age effect on lung development. The SARP cohort is well phenotyped with a relatively large sample size (n 5 618) and has a broad range of lung function, and thus SARP was used as the primary population for this analysis.
After a quality control process, 1,544 subjects from the 4 studies were analyzed with the shared 369,771 SNPs for association with predrug spirometric measures of lung function: ppFEV 1 , ppFVC, and FEV 1 /FVC ratio. ppFEV 1 was the primary phenotype in this study because it is the lung function measure most used for clinical studies in asthmatic subjects.
Meta-analysis of GWASs of ppFEV 1
Forty-four SNPs from 32 independent loci were suggestively associated with ppFEV 1 values (P < 10 24 ; Fig 1 and (Tables I and II and see Table E3 in this article's Online Repository at www.jacionline.org).
These 4 T H 1 pathway SNPs cumulatively explained 2.9% to 7.8% of the variance in ppFEV 1 values in 4 populations, with a meta-analysis P value of 3 3 10 211 (Table II) . The possession of an increased number of risk alleles (genetic scores) for these 4 SNPs inversely correlated with ppFEV 1 values (P 5 2 3 10
27
) and positively correlated with the ATS asthma severity classification (P 5.005) in the SARP population (Fig 2) . In the SARP cohort ppFEV 1 values displayed a stepwise decrease from 81.9 (SD, 20.1) to 76.6 (SD, 21.1) and then to 65.1 (SD, 22.3), and the percentage of subjects with severe asthma (based on ATS classification) showed an increase from 40.2% to 49.4% and then to 64.3% with the increasing number of risk alleles (Fig 2) .
Meta-analyses of GWASs of ppFVC and FEV 1 /FVC ratio values
Thirty-nine SNPs were suggestively associated with ppFVC values (P < 10
24 , see Table E4 in this article's Online Repository at www.jacionline.org). Two SNPs downstream of IL12RB1 (rs12984174 and rs388159 in moderate LD: r 2 5 0.75) ranked as number 1 and number 9. rs388159 was also the top candidate SNP associated with ppFEV 1 values (Table I) , making it the most robust finding in this study.
Thirty-one SNPs were suggestively associated with FEV 1 /FVC ratio values (P < 10
24 , see Table E5 in this article's Online Repository at www.jacionline.org). rs11032873, which is located between APIP and EHF, was associated with FEV 1 /FVC ratio values (P 5 3.1 3 10
25
). The APIP-EHF region has been identified as a modifier locus of lung disease severity in patients with cystic fibrosis. 18 Two adenylate cyclase family genes (ADCY2 and ADCY9) were associated with FEV 1 /FVC ratio values (P 5 5.6 3 10 25 or 6.3 3 10 25 for rs12659620 or rs2230739, respectively). rs3130696, which is located upstream of HLA-C, was associated with FEV 1 /FVC ratio values (P 5 7.3 3 10 25 ).
Replication of 28 normal lung function loci
Two meta-analyses of GWASs in approximately 20,000 healthy subjects of European descent have identified 12 loci for lung function 6, 7 : HHIP, HTR4, INTS12-GSTCD-NPNT, and TNS1 for FEV 1 and ADAM19, DAAM2, FAM13A, GPR126, HHIP, HTR4, NOTCH4-AGER-PPT2, PID1, PTCH1, and THSD4 for FEV 1 /FVC ratio (see Table E6 in this article's Online Repository at www.jacionline.org). One more recent meta-analysis of GWASs in approximately 90,000 healthy subjects of European descent has identified 16 novel loci for lung function 5 : C10orf11, CDC123, MECOM, and ZKSCAN3-ZNF323 for FEV 1 and ARMC2, CCDC38, CDC123, CFDP1, HDAC4, KCNE2, LRP1, MFAP2, MMP15, NCR3, RARB, SPATA9, and TGFB2 for FEV 1 /FVC ratio (see Table E7 in this article's Online Repository at www.jacionline.org).
In this study we replicated 7 of 28 lung function loci at SNP levels (P < .05) for the same phenotypes and in the same effect direction in asthma: HHIP (rs1980057 and rs7670758), FAM13A (rs2869967 and rs6825998), THSD4 (rs12899618), GSTCD (rs17035917 and rs6820671), NOTCH4-AGER (rs206015), RARB (rs1529672 and rs7616278), and ZNF323 (rs6922111 and rs1416920, see Tables E6 and E7) .
Comparison of asthma genes and lung function genes
Although lung function is an essential intermediate phenotype distinct between asthmatic patients and healthy subjects, the genes associated with lung function were largely not associated with asthma susceptibility in the GABRIEL study (extracted from J ALLERGY CLIN IMMUNOL VOLUME 132, NUMBER 2 the European Genome-Phenome Archive; http://www.cng.fr/ gabriel; accession no. EGAS00000000077). 19 In this study the 4 T H 1 pathway SNPs associated with lung function were not associated with asthma susceptibility in the GABRIEL, 19 TENOR, 11 or SARP/CSGA 20 studies (see Table  E8 in this article's Online Repository at www.jacionline.org). Six SNPs (in ORMDL3-GSDMB, IL33, IL1RL1-IL18R1, TSLP, IL13, and HLA-DRA) associated with asthma susceptibility [19] [20] [21] were not associated with ppFEV 1 values (see Table E9 in this article's Online Repository at www.jacionline.org).
Two-step asthma progression genetic model
On the basis of this study and previous findings, we suggest a 2-step asthma progression genetic model (Fig 3) . In the first step genetic variants in T H 2 pathway genes (IL13, TSLP, IL33, and IL1RL1), interacting with environmental factors, induce T H 2-dominant response and atopy, which distinguish subjects with asthma from healthy subjects. In the second step genetic variants in the T H 1 or IL-12 cytokine family pathway (IL12A, IL12RB1, STAT4, and IRF2), airway structure/remodeling (HHIP, FAM13A, THSD4, GSTCD, NOTCH4-AGER, RARB, and ZNF323), and/or other mechanisms interacting with environmental factors lead to lower lung function and increased asthma severity.
DISCUSSION
In this study we investigated genetic variants related to lung function in 4 European American asthmatic populations (n 5 1544) using GWASs and meta-analyses. Although the sample size is relatively small compared with that of the studies in general populations, the current study is the first and largest GWAS of lung function in comprehensively phenotyped subjects with asthma. Further replication in well-phenotyped independent populations is essential to confirm our findings. Three predrug spirometric measures of lung function (ppFEV 1 , ppFVC, and FEV 1 /FVC ratio) were studied. FEV 1 is the volume of air that can be expired forcibly in 1 second after full inspiration. FVC is the volume of air that can be expired forcibly after full inspiration. The FEV 1 /FVC ratio is the ratio of FEV 1 to FVC. Both FEV 1 and FVC values can be decreased in patients with respiratory diseases but might not be in the same proportion. These 3 measures are correlated but might reflect fine differences in lung function. The FEV 1 /FVC ratio and FEV 1 reflect airway obstruction and the grade of airway obstruction and thus are used together to define chronic obstructive pulmonary disease. ppFEV 1 was the primary phenotype in this study because it is highly correlated with asthma severity and mostly used for clinical studies in asthmatic subjects. Although no SNP reached genome-wide significance (P 5 5 3 10 28 ), multiple SNPs were suggestively associated with ppFEV 1 , ppFVC, or FEV 1 /FVC ratio values (P < 10 24 , see Tables E2, E4 , and E5). In general, the results for these 3 measurements agreed well, although the top SNPs were not always the same in the 3 measurements (see Table E2 ). More importantly, multiple top SNPs belong to the same pathway and are functionally related to lung function. The same effect direction of these SNPs in all 4 studied populations further supports our results. Although a single SNP with a modest P value does not meet the strict requirements for association in a GWAS analysis, multiple independent loci mapped to the same biological pathway are very unlikely to be a result of chance, and thus pathway analysis is an important complementary approach to a GWAS. STAT4, and IRF2 (Table I) . Although these 4 SNPs were not significant individually at the genome-wide level, cumulatively they explained 2.9% to 7.8% of the variance in ppFEV 1 values (P 5 3 3 10
211
, Table II ). In the well-phenotyped SARP population genetic scores of these 4 SNPs were inversely associated with ppFEV 1 values (P 5 2 3 10
27
) and positively associated with the ATS asthma severity classification (P 5 .005). The risk allele of IL12RB1, STAT4, and IRF2 is its major allele, and the risk allele of IL12A is its minor allele. In general, the combinations of risk alleles involving IRF2 were correlated with higher ppFEV 1 values, and those including IL12A were associated with lower ppFEV 1 values (see Table E10 in this article's Online Repository at www.jacionline.org). IL-12 is a key cytokine that modulates innate and adaptive immune responses. IL-12 is a heterodimer composed of the p35 subunit (encoded by IL12A) and the p40 sub SNPs in the STAT4 region have been associated with systemic lupus erythematosus, [29] [30] [31] systemic sclerosis, 32 rheumatoid arthritis, 33, 34 and primary biliary cirrhosis. 27 Candidate gene studies have indicated that IL12RB1, STAT4, and IRF2 were associated with asthma, but the association results are not consistent. 35 Several genes associated with lung development or height were identified (see Tables E2, E4 , and E5), including HHIP, [5] [6] [7] SULF1, 36 and SYN3, 36,37 although ppFEV 1 and ppFVC values were already adjusted for height. Similarly, GWASs of lung function in general populations also identified multiple genes associated with height, [5] [6] [7] indicating the importance of height in determining lung volume or pulmonary function.
Two adenylate cyclase family genes (ADCY2 and ADCY9) were suggestively associated with FEV 1 /FVC ratio values (see Table E5 ). The same nonsynonymous coding SNP (rs2230739 or Ile772Met) in ADCY9 has been shown to be significantly associated with the difference in improvement of FEV 1 values with the response to b-agonist with or without corticosteroid treatment. 38 In a candidate gene study ADCY2 was associated with both chronic obstructive pulmonary disease and FEV 1 /FVC ratio values independently of smoking effect. 39 Previously, we have shown that a subset of genes that regulate lung function in general populations might be associated with abnormal lung function in subjects with asthma. 8 In this study this list has been extended to 7 of 28 lung function loci at the SNP level: HHIP (rs1980057 and rs7670758), FAM13A (rs2869967 and rs6825998), THSD4 (rs12899618), GSTCD (rs17035917 and rs6820671), NOTCH4-AGER (rs206015), RARB (rs1529672 and rs7616278), and ZNF323 (rs6922111 and rs1416920, see Tables E6 and E7) . Among these 7 genes, several might be involved in airway structure and airway remodeling: (1) HHIP might influence embryonic lung-branching morphogenesis 40 ; (2) RARB is an inhibitor of the perinatal formation of pulmonary alveoli 41 ; and (3) NOTCH4 and THSD4 might be involved in angiogenesis and airway remodeling. 42, 43 Furthermore, both TIMP3 and CITED2, which are associated with ppFEV1 values (see Table  E2 ), might be involved in hypoxia-inducible factor 1a/vascular endothelial growth factor-induced hypoxia and angiogenesis. 44, 45 In the GABRIEL study 19 the 12 lung function loci 6, 7 were not associated with asthma susceptibility. In this study the 4 T H 1 pathway SNPs associated with lung function were not associated with asthma susceptibility (see Table E8 ); conversely, 6 SNPs (in ORMDL3-GSDMB, IL33, IL1RL1-IL18R1, TSLP, IL13, and HLA-DRA) conferring asthma susceptibility [19] [20] [21] were not associated with ppFEV 1 values (see Table E9 ). These results indicate that genes associated with lung function that can modify asthma severity might be distinct from those genes associated with asthma susceptibility. Thus we hypothesize that asthma would develop in a subject with susceptibility loci but that more severe asthma with reduced lung function requires the presence of additional severity or pulmonary function loci.
GWASs in subjects with autoimmune diseases have consistently identified IL12A [23] [24] [25] [26] [27] [28] and STAT4 27,29-34 regions. The top SNPs of STAT4 identified in autoimmune diseases are not in strong LD with the top SNPs identified in this study, indicating that distinct transcription regulation mechanisms might exist in different tissues for autoimmune diseases and asthma. However, evidence from genetic association studies indicates the opposite direction of effect size for STAT4 between autoimmune diseases and ppFEV 1 values. For example, the minor allele T of rs10168266 in STAT4 is the risk allele for primary biliary cirrhosis (P 5 4.2 3 10 25 ) 24 but the protective allele for ppFEV 1 (P 5 .028). The minor allele A of rs3821236 is the risk allele for systemic lupus erythematosus (P 5 8.5 3 10 211 ) 30 but the protective allele for ppFEV 1 (P 5 .036). The minor allele T of rs7574865 is the risk allele for systemic lupus erythematosus in subjects of Chinese (P 5 5.2 3 10 242 ) 31 or European (P 5 9.0 3 10 214 ) 29 descent but possibly the protective allele for ppFEV 1 (P 5.093). The minor allele T of rs925847 is the protective allele for ppFEV 1 (P 5 8.2 3 10
25
) and eczema (P 5 .014) 46 but the major risk allele for ulcerative colitis in the Korean population (P 5 .025). 47 In general, the expression of T H 1 pathway genes is believed to be increased in subjects with autoimmune diseases, and thus the expression of T H 1 pathway genes might be positively correlated with ppFEV 1 values or negatively correlated with asthma severity (Fig 3) .
The T H 1 pathway primarily acts against viruses and bacterial infections. Respiratory tract virus infection might initiate and exacerbate asthma. The decrease in production of IFN-g in response to viral infection of monocytes at birth predicts the susceptibility to respiratory tract illness during the first year of life. 48 The weaker T H 1 responses to viral infection are associated with asthma exacerbations and suggest that viral infection can exacerbate a pre-existing T H 2-dominated lung disease. 49 In a study of acute asthma exacerbations in children, 50 the expression of T H 1 pathways genes is decreased during exacerbation, with deficits in baseline lung function. Rhinovirus-induced clinical phenotypes are more severe in asthmatic subjects than healthy control subjects and indicate impaired T H 1 or augmented T H 2 immune responses. 51 The weaker T H 1 response might strengthen the T H 2-dominated response in asthmatic subjects, whereas the impaired T H 1 response against viral infection might extend the inflammation process and lead to airway remodeling (Fig 3) .
We must emphasize the complexity of immunologic pathways. Although we speculated that the T H 1 pathway might be important for lung function in asthmatic subjects, the genes identified (IL12A, IL12RB1, STAT4, and IRF2) could be involved in other pathways. For example, IL-12p35, encoded by IL12A, is a ligand subunit shared by IL-12 and IL-35, where IL-35 might be involved in the regulatory T-cell pathway. 52 IL-12Rb1, which is encoded by IL12RB1, is a receptor subunit shared by IL-12 and IL-23, where IL-23 is a proinflammatory cytokine involved in the T H 17 pathway. 52 More comprehensively, we can label IL12A, IL12RB1, STAT4, and IRF2 as IL-12 cytokine family pathway genes.
On the basis of this study and previous findings, we propose a simplified 2-step genetic model of asthma progression (Fig 3) . Genetic variants in T H 2 pathway genes (IL13, TSLP, IL33, and IL1RL1) induce T H 2-dominant response, atopy, and asthma susceptibility. Genetic variants in T H 1 or IL-12 cytokine family pathway genes (IL12A, IL12RB1, STAT4, and IRF2), airway structure/ remodeling (HHIP, FAM13A, THSD4, GSTCD, NOTCH4-AGER, RARB, and ZNF323), and/or other mechanisms affect lung function and increase asthma severity and asthma exacerbation.
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Key messages
d Genes involved in airway structure/remodeling are associated with lung function in both general populations and subjects with asthma. 
